S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Sean Maraynes Returns to Wilson Elser as Medical Malpractice Partner

After a six-year departure, trial attorney Sean Maraynes has rejoined Wilson Elser as a partner in the firm’s White Plains office. Maraynes, who previously served as of counsel, brings extensive experience in defending high-exposure medical malpractice and catastrophic personal injury litigation throughout the New York metropolitan region.

Sean Maraynes Returns to Wilson Elser as Medical Malpractice Partner
Photo: Bio & News

Maraynes spent the last six years at a New York defense litigation firm, building a portfolio that spans wrongful death, nursing home negligence, and complex construction litigation. With more than 40 trials to his credit, he has navigated courtrooms across all five boroughs of New York City and surrounding counties. His appointment strengthens Wilson Elser’s regional bench, which currently encompasses over 400 attorneys across New York City, White Plains, and Long Island.

Lori Semlies, cochair of the firm's Medical Malpractice & Health Care Practice, noted that Maraynes’ background in high-stakes casualty matters aligns with the firm’s strategy for handling technical defense cases. Before his initial stint at Wilson Elser, Maraynes served five years as an Assistant District Attorney in Bronx County, where he prosecuted a range of violent crimes, including homicides. A member of the American Board of Trial Advocates, he holds a law degree from the Benjamin N. Cardozo School of Law.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!